#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4420791	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in cell number at 5 to 40 uM incubated up to 2 days	Homo sapiens	41	ALA4420072	cell-based format	Patent Bioactivity Data
2.	ALA4420792	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as inhibition of S-phase progression at 20 uM followed by BrdU addition and incubated for 24 hrs by immunofluorescent staining	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
3.	ALA4420793	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as restoration of cell-cell contact at 20 uM by E-cadherin and beta-catenin detection based immunofluorescent staining	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
4.	ALA4420795	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in p27Kip1 expression by Western blotting analysis	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
5.	ALA4420796	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in pS10 p27Kip1 expression by Western blotting analysis	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
6.	ALA4420797	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in pY77 FAK expression by Western blotting analysis	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
7.	ALA4420798	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in alpha-SMA expression by Western blotting analysis	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
8.	ALA4420799	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in cytosolic p27Kip1 expression by immunofluorescent staining	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
9.	ALA4420800	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as restoration of reduced RhoA activity	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
10.	ALA4420801	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as induction of return of elongated cell shape to polygonal shape by DAPI staining based assay	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
11.	ALA4420802	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as increase in sensitivity of N-linked glycosylated region of TM4SF5 to PNGase F	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
12.	ALA4420804	B	Inhibition of TM4SF5 in human SNU368 cells assessed as reduction in cell number at 1 to 20 ug/ml incubated up to 3 days	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
13.	ALA4420805	B	Inhibition of TM4SF5 in human HepG2 cells assessed as reduction in cell number at 1 to 20 ug/ml incubated up to 3 days	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
14.	ALA4420806	B	Inhibition of TM4SF5 in human HuH7 cells assessed as reduction in cell number at 1 to 20 ug/ml incubated up to 3 days	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
15.	ALA4420812	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in cell migration at 20 uM incubated for 18 hrs by Transwell chamber based assay	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
16.	ALA4420813	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in cell invasion into collagen gel matrix at 20 uM incubated for 18 hrs	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
17.	ALA4420814	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in cell invasion into Matrigel gel matrix at 20 uM incubated for 24 hrs	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
18.	ALA4420815	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in MMP2 activity gel at 20 uM incubated for 24 hrs followed by medium exchange with serum-free medium and further incubated for 18 hrs by zymography	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
19.	ALA4420816	B	Inhibition of TM4SF5 in human SNU449Tp cells assessed as reduction in MMP9 activity gel at 20 uM incubated for 24 hrs followed by medium exchange with serum-free medium and further incubated for 18 hrs by zymography	Homo sapiens	1	ALA4420072	cell-based format	Patent Bioactivity Data
20.	ALA4420817	B	Activation of TM4SF5 in human SNU449Tp cells in monolayer arrangement assessed as stimulation of cell growth at 20 uM incubated for 24 hrs by optical microscopy	Homo sapiens	3	ALA4420072	cell-based format	Patent Bioactivity Data